Formulation Development

Formulation Development
Product Description

BioDuro-Sundia holds more than 25 years of experience formulating poor solubility and  poor permeability drugs for the clinical studies. Our comprehensive suite of advanced formulation technologies and extensive scientific know-how supports >95% of marketed dosage forms.

Pre-formulation & Discovery Support

  • Solubility, stability, compatibility, logP testing
  • Solid form screening & selection
  • Physicochemical profiling, drug ability assessment
Formulation & Process Development
  • Process development based on physicochemical and physical properties of drug candidates
  • Storage and shipping conditions assessment of drug candidates
  • Technology transfer of formulation and manufacturing process to clinical manufacturing sites
  • CMC document preparation for IND/NDA/ANDA submission
Filing Document Preparation
  • CMC document preparation and regulatory support
  • NMPA/FDA/EMA/TFDA dossier filling support
Pre-formulation Development
  • pH/Aqueous Solubility
  • Solid state characterization
  • Intrinsic Properties Profiling & Dissolution
  • Polymorph screening
  • Salt screening
  • Co-crystal Screening
  • Crystallization Process
SOLUBILITY ENHANCEMENT
  • Amorphous Solid Dispersion Development
  • Micronization
  • Nano-suspensions
  • SEDDS/SMEDDS
  • Evaluation at Lead Selection / Early Tox stage
TASTE MASKING STRATEGIES
  • Reduce drug/taste bud interaction utilizing API-excipient Complexation strategies
  • Improve taste profiles of Orally Dispersible Tablets (ODT) by suspension & multiple/dual emulsion technologies
  • Protect against salivary pH response by application of stimuli-responsive coatings
  • Functionally coat your drug using Reverse Enteric Polymers
HIGH POTENT FORMULATIONS
Pediatric Dosage Deliver

Read more Show less

BioDuro

  • Country/Region:
    United States
  • Founded:
    1996
  • On CPHI since:
    2018
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
Contract Service
View company profile
Categories
more categories Show less
Sales Markets
Show more Show less

BioDuro

  • Country/Region:
    United States
  • Founded:
    1996
  • On CPHI since:
    2018
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
Contract Service
View company profile

More Products from BioDuro (4)

  • Drug Product Manufacturing

    Product Drug Product Manufacturing

    BioDuro-Sundia's Drug Product manufacturing services support clinical and commercial scale GMP production for a comprehensive range of oral solid dosage forms, including: solid, liquid, and semi solid dosage forms. This includes fully-audited manufacturing facilities (FDA and other regulators) with excepti...
  • Drug Substance

    Product Drug Substance

    BioDuro-Sundia’s Drug Substance manufacturing services support production of small molecule APIs, RSMs and intermediates--both GMP and non-GMP .  We provide a full range of production scale, supporting all stages of drug substance development through IND submission.  Fully integrated CMC ser...
  • Process Development

    Product Process Development

    BioDuro-Sundia’s process development services support drug substance production,  providing an efficient path to manufacture API or intermediates. Our extensive services support production of API for GLP toxicology studies, IND-enabling studies, clinical studies, and commercialization efforts. qq...
  • Analytical Development

    Product Analytical Development

    BioDuro-Sundia’s Analytical Testing team offers high quality analytical services including method development and validation, qualification of reference standards, testing and release studies, stability studies, and CMC dossier preparation services. ...